Patents Assigned to Neuralab Limited
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040247590
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Application
    Filed: July 13, 2004
    Publication date: December 9, 2004
    Applicant: Neuralab Limited
    Inventors: Dale B. Schenk, Frederique Bard, Theodore Yednock
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040247591
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Application
    Filed: July 12, 2004
    Publication date: December 9, 2004
    Applicant: Neuralab Limited
    Inventors: Dale B. Schenk, Frederique Bard, Theodore Yednock
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040228865
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: November 18, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6818218
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune reponse against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: November 16, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040219146
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide, active fragments thereof or an antibody thereto.
    Type: Application
    Filed: April 19, 2004
    Publication date: November 4, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6808712
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response an amyloid deposit in the patient. The methods are particularly useful for prophylatic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: October 26, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
    Publication number: 20040175394
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: September 9, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • N-Terminal amyloid-&bgr; antibodies
    Patent number: 6787637
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787143
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787140
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787139
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787144
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787523
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787138
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
    Publication number: 20040170641
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: September 2, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040166119
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: August 26, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040157779
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: August 12, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Passive immunization treatment of Alzheimer's disease
    Patent number: 6761888
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: July 13, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Humanized and chimeric N-terminal amyloid beta-antibodies
    Patent number: 6750324
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: June 15, 2004
    Assignee: Neuralab Limited
    Inventors: Dale B. Schenk, Frederique Bard, Theodore Yednock
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6743427
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: June 1, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk